Cisplatin and derived anticancer drugs: mechanism and current status of DNA binding.
Bloemink
M J
MJ
Leiden Institute of Chemistry, Gorlaeus Laboratories, Leiden University, The Netherlands.
Reedijk
J
J
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000627:therapeutic use / Q000633:toxicity; D001483:Base Sequence; D016190:Carboplatin / Q000737:chemistry; D002945:Cisplatin / Q000031:analogs & derivatives* / Q000737:chemistry* / Q000627:therapeutic use / Q000633:toxicity; D004247:DNA / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000188:drug therapy; D009690:Nucleic Acid Conformation; D009838:Oligodeoxyribonucleotides / Q000737:chemistry*; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D009838:Oligodeoxyribonucleotides; D004247:DNA; D016190:Carboplatin; D002945:Cisplatin